Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA).
about
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meetingUse of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study.Comparative statistical analysis of osteoporosis treatment based on Hungarian claims data and interpretation of the results in respect to cost-effectiveness.Women's lived experiences of learning to live with osteoporosis: a longitudinal qualitative study.Evaluating beneficial drug effects in a non-interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data.Challenges in implementing and maintaining osteoporosis therapy.Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in SpainEarly (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study.Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysisCompliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis.Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer PerspectiveUpper gastrointestinal safety and tolerability of oral alendronate: A meta-analysisCan Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?Which Bisphosphonate? It's the Compliance!: Decision Analysis.Premenopausal women with a distal radial fracture have deteriorated trabecular bone density and morphology compared with controls without a fractureAdherence to osteoporosis regimens among men and analysis of risk factors of poor compliance: a 2-year analytical review.Women's experiences of their osteoporosis diagnosis at the time of diagnosis and 6 months later: a phenomenological hermeneutic study.Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United StatesThe importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis.Adherence with medications used to treat osteoporosis: behavioral insights.Bisphosphonate use and subsequent hip fracture in South Korea.Swedish osteoporosis care.Non-adherence with bisphosphonates among patients with osteoporosis: impact on fracture risk and healthcare cost.Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.Management of oral bisphosphonates treatment by rheumatologists and determinants of therapeutic changes: a case-vignette-based study.Adherence to osteoporosis medicines in Estonia-a comprehensive 15-year retrospective prescriptions database study.A Retrospective Longitudinal Database Study of Persistence and Compliance with Treatment of Osteoporosis in Hungary.Anti-osteoporotic therapy in Denmark--predictors and demographics of poor refill compliance and poor persistence.Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis.Influence of refill adherence method when comparing level of adherence for different dosing regimens.Validity of self-reported osteoporosis in mid-age and older women.A health economic simulation model for the clinical management of osteoporosis.Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates.Residual effect after oral bisphosphonate treatment and healthy adherer effects--the Swedish Adherence Register Analysis (SARA).Improved real-life adherence of 6-monthly denosumab injections due to positive feedback based on rapid 6-month BMD increase and good safety profile.Adherence to Bisphosphonates among People Admitted to an Orthopaedic and Geriatric Ward at a University Hospital in Sweden.Adherence and persistence of patients using oral bone sparing drugs in primary care.The Hidden Burden of Fractures in People Living With HIV
P2860
Q30234621-1DDE0003-D2A3-46BD-9F88-70493AEE3110Q30641539-FD8B3BA0-1A9C-487D-88EF-68C8405B6359Q30819137-577FCC68-7308-452C-BBC7-BD195B6EE8F2Q30841438-8053F4BE-56FA-4861-93E7-072BFE6AAC62Q31147482-5762DDB6-2DB1-4DD3-A85F-DE10B2A72C09Q34073740-B1821A95-4E8A-4C32-9234-F1FB6A6C94E1Q35087883-EE30FC03-AB85-462A-BB57-E83FBA08D8CFQ35707347-2FB327B3-D023-48B9-97F5-6629AF47EA0CQ36073645-DB6284E1-3517-4710-9877-2D9CD87A1B8AQ36343783-94A03D02-9568-483C-9545-2692119F7635Q36400967-1896804B-AB7C-4024-8461-D54C91BD5698Q36502735-7748DADB-9C74-42C9-A2F4-B806757DA3FCQ36989616-5AEA3B3F-42FF-47D8-A152-F6763893578BQ36989633-F5883B14-3692-4240-8FAC-EFD87F95003AQ37109419-5145262C-6C39-4E91-8833-BE3EA6AD82F2Q37360702-B268DA23-8059-4036-B133-2E7A2E0F13D2Q37604443-D2E134D0-82C1-4919-B76A-D9B07EBBE74EQ37670574-54907E46-AD59-4131-9025-0269EB628F1BQ37998122-E33ABBD3-6AEE-426B-9A81-2A0CBB50BAADQ38075457-AD9A495E-792D-46DC-A301-5BD1FE1712BFQ38107388-97A741AE-97C8-42AE-B199-78584488735EQ38563886-82CE8B02-9A2C-4C5E-BA41-489276759E90Q38788967-2489D40C-BABF-43C9-83D9-DFC3583B1A91Q39264339-0FF9A834-6891-407B-BDC4-C83B664F11D4Q40065539-317A7A93-B479-4F46-9491-D30BCC8C74CBQ40148523-70786199-8DC6-44EA-9F1F-F2EEEAB80F08Q40189823-577AEAF9-CE18-46D1-BA4E-3DECE58EA12CQ43678564-48C8AA1B-C2E5-4257-AE6A-D05DE52604DDQ44065014-D14431C8-568F-4764-9043-60E76622250EQ44131390-20173A62-99C7-459F-AECE-EFC197288840Q46570104-5E361582-E23E-40BA-9ADD-BDB12AA04D05Q48193001-B5D8EA69-0F56-4DE0-864B-1EA732933EF4Q49630595-4DD17DC9-0CA4-48B2-A621-21DCB079E1C6Q50629864-2F31493A-E1F9-45BE-8944-DE1BCAB9D5B1Q50764107-23C039C2-4C42-4CD0-A71C-A37848088139Q52679043-2435FB74-BAEA-494C-8BF3-DF1F55CDBC57Q53407067-B7C07F0B-296A-4A3C-A165-03917BD5578AQ57143538-DE6C7C7F-243B-4E4F-8480-340B7BD181B4
P2860
Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Adherence to treatment of prim ...... ence Register Analysis (SARA).
@en
Adherence to treatment of prim ...... sh Adherence Register Analysis
@nl
type
label
Adherence to treatment of prim ...... ence Register Analysis (SARA).
@en
Adherence to treatment of prim ...... sh Adherence Register Analysis
@nl
prefLabel
Adherence to treatment of prim ...... ence Register Analysis (SARA).
@en
Adherence to treatment of prim ...... sh Adherence Register Analysis
@nl
P2093
P2860
P1476
Adherence to treatment of prim ...... ence Register Analysis (SARA).
@en
P2093
P2860
P2888
P304
P356
10.1007/S00198-011-1549-6
P407
P577
2011-02-01T00:00:00Z